Registration - Amendment

INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH for INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Regulation of stem cell-based therapies, funding for biomedical research, regulation of stem cell research.

LobbyistCovered position, as disclosed
ERIC D ANTHONY New Legislative Director, Congresswoman Rosa L. DeLauro, Legislative Assistant, Congressman Anthony Weiner
MEGAN DONOVAN New —

Science/Technology SCI

Regulation of stem cell-based therapies, funding for biomedical research, regulation of stem cell research.

LobbyistCovered position, as disclosed
ERIC D ANTHONY New Legislative Director, Congresswoman Rosa L. DeLauro, Legislative Assistant, Congressman Anthony Weiner
MEGAN DONOVAN New —

Health Issues HCR

Regulation of stem cell-based therapies, funding for biomedical research, regulation of stem cell research.

LobbyistCovered position, as disclosed
ERIC D ANTHONY New Legislative Director, Congresswoman Rosa L. DeLauro, Legislative Assistant, Congressman Anthony Weiner
MEGAN DONOVAN New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.